Pathstone Family Office’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,000
| Closed | -$3K | – | 1394 |
|
|
2020
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 985 |
|
|
2020
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 693 |
|
|
2020
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 612 |
|
|
2020
Q1 | $4K | Buy |
+1,000
| New | +$4K | ﹤0.01% | 648 |
|
|
2019
Q4 | – | Sell |
-1,000
| Closed | -$8K | – | 648 |
|
|
2019
Q3 | $8K | Buy |
+1,000
| New | +$8K | ﹤0.01% | 509 |
|
|
2019
Q2 | – | Sell |
-1,000
| Closed | -$5K | – | 944 |
|
|
2019
Q1 | $5K | Buy |
+1,000
| New | +$5K | ﹤0.01% | 612 |
|